Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Targeted cancer therapies often cause skin side effects, needing dermatologist care.

Cancer prevention has advanced significantly, with some strategies proving successful.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Taking too much Albendazole can cause hair loss and other serious side effects.

Taking too much Albendazole can cause hair loss and other serious side effects.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

The botanical treatment for hair loss shows promise, especially for children.

Wnt-activating drugs generally do not increase cancer risk.

Docetaxel chemotherapy causes more long-term hair loss and dissatisfaction than paclitaxel.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Scalp cooling can help reduce hair loss during chemotherapy.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.